Stocksigma LogoStocksigma Logo

iSERA Lifesciences Reports Q2FY27 Standalone Net Loss of ₹13.11 Lakhs

iSERA Lifesciences reported standalone net loss of ₹13.11 lakhs for the quarter ended 30th Sep'26, narrowing QoQ from a loss of ₹33.62 lakhs in Jun'26

iSERA Lifesciences Reports Q2FY27 Standalone Net Loss of ₹13.11 Lakhs

iSERA Lifesciences Ltd · Financial Result · 05 Nov 2026, 3:01 am

iSERA Lifesciences Reports Q2FY27 Standalone Net Loss of ₹13.11 Lakhs iSERA Lifesciences reported standalone net loss of ₹13.11 lakhs for the quarter ended 30th Sep'26, narrowing QoQ from a loss of ₹33.62 lakhs in Jun'26, compared to a profit of ₹0.70 lakhs in 30th Sep'25. Revenue from operations remained nil, while other income stood at ₹7.88 lakhs. Total expenses were ₹20.99 lakhs versus ₹33.62 lakhs in the prior quarter. For H1FY27, net loss widened to ₹46.73 lakhs from ₹0.84 lakhs YoY. Basic and diluted EPS for the quarter was negative ₹0.62.

Original exchange filing (PDF)

More announcements from iSERA Lifesciences Ltd

All iSERA Lifesciences Ltd announcements